KOR

e-Article

Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study
Document Type
Article
Source
In The Lancet 17 December 2016-6 January 2017 388(10063):3017-3026
Subject
Primary Research
Articles
Language
ISSN
0140-6736